[HTML][HTML] A two-step model for colon adenoma initiation and progression caused by APC loss
RA Phelps, S Chidester, S Dehghanizadeh, J Phelps… - Cell, 2009 - cell.com
Aberrant Wnt/β-catenin signaling following loss of the tumor suppressor adenomatous
polyposis coli (APC) is thought to initiate colon adenoma formation. Using zebrafish and human …
polyposis coli (APC) is thought to initiate colon adenoma formation. Using zebrafish and human …
[HTML][HTML] DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APC
…, KF Grossmann, LD Nadauld, S Dehghanizadeh… - Cell, 2010 - cell.com
Although genome-wide hypomethylation is a hallmark of many cancers, roles for active DNA
demethylation during tumorigenesis are unknown. Here, loss of the APC tumor suppressor …
demethylation during tumorigenesis are unknown. Here, loss of the APC tumor suppressor …
[HTML][HTML] SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates
…, R Moazzami, SM Hashemi, S Dehghanizadeh… - NPJ vaccines, 2022 - nature.com
At the forefront of biopharmaceutical industry, the messenger RNA (mRNA) technology offers
a flexible and scalable platform to address the urgent need for world-wide immunization in …
a flexible and scalable platform to address the urgent need for world-wide immunization in …
[HTML][HTML] Active BRAF-V600E is the key player in generation of a sessile serrated polyp-specific DNA methylation profile
S Dehghanizadeh, V Khoddami, TL Mosbruger… - PLoS …, 2018 - journals.plos.org
Background Sessile serrated polyps (SSPs) have emerged as important precursors for a large
number of sporadic colorectal cancers. They are difficult to detect during colonoscopy due …
number of sporadic colorectal cancers. They are difficult to detect during colonoscopy due …
Safety and immunogenicity of COReNAPCIN, a SARS-CoV-2 mRNA vaccine, as a fourth heterologous booster in healthy Iranian adults: A double-blind, randomized …
…, H Hosseini, SM Hashemi, S Dehghanizadeh… - International …, 2024 - Elsevier
The recurrent COVID-19 infection, despite global vaccination, highlights the need for booster
doses. A heterologous booster has been suggested to enhance immunity and protection …
doses. A heterologous booster has been suggested to enhance immunity and protection …
Development of transgenic mice expressing calcitonin as a beta-lactoglobulin fusion protein in mammary gland
A Niavarani, S Dehghanizadeh, S Zeinali, M Karimi… - Transgenic …, 2005 - Springer
Expression of foreign proteins in mammalian milk is becoming a widespread strategy for
high-level production of recombinant pharmaceuticals, especially those with the most complex …
high-level production of recombinant pharmaceuticals, especially those with the most complex …
Safety and immunogenicity of COReNAPCIN®, a SARS-CoV-2 mRNA vaccine; a randomized, double-blind, placebo-controlled phase 1 clinical trial
…, M Azimi, H Hosseini, SM Hashemi, S Dehghanizadeh… - medRxiv, 2023 - medrxiv.org
The repeated COVID-19 outbreaks, despite global vaccination, highlights the need for booster
doses. Here, we present the outcomes, up until day 90 post vaccination, of a randomized, …
doses. Here, we present the outcomes, up until day 90 post vaccination, of a randomized, …
mRNA-based vaccine candidate COReNAPCIN® induces robust humoral and cellular immunity in mice and non-human primates
…, R Moazzami, SM Hashemi, S Dehghanizadeh… - bioRxiv, 2022 - biorxiv.org
At the forefront of biopharmaceutical industry, the messenger RNA (mRNA) technology offers
a flexible and scalable platform to address the urgent need for world-wide immunization in …
a flexible and scalable platform to address the urgent need for world-wide immunization in …
mRNA-based vaccine candidate COReNAPCIN (R) induces robust humoral and cellular immunity in mice and non-human primates (preprint)
…, R Moazzami, SM Hashemi, S Dehghanizadeh… - 2022 - pesquisa.bvsalud.org
At the forefront of biopharmaceutical industry, the messenger RNA (mRNA) technology offers
a flexible and scalable platform to address the urgent need for world-wide immunization in …
a flexible and scalable platform to address the urgent need for world-wide immunization in …
Development of transgenic mice expressing calcitonin as a beta-lactoglobulin fusion protein in mammary gland.
…, SD Somaye Dehghanizadeh… - 2005 - cabidigitallibrary.org
Expression of foreign proteins in mammalian milk is becoming a widespread strategy for
high-level production of recombinant pharmaceuticals, especially those with the most complex …
high-level production of recombinant pharmaceuticals, especially those with the most complex …